Publication | Closed Access

A Randomized, Placebo-Controlled Phase II Study Evaluating the Reduction of Neutropenia and Febrile Neutropenia in Patients With Colorectal Cancer Receiving Pegfilgrastim With Every-2-Week Chemotherapy

Surgical OncologyEvery-2-week ChemotherapyGastrointestinal OncologyMedicinePathologyColorectal CancerFebrile NeutropeniaCancer TreatmentOncologyRadiation Oncology